NEW YORK (GenomeWeb) – CareDx said today that it expects to report fourth quarter revenues of $12.3 million to $12.5 million, an increase of 13 percent to 15 percent over Q4 2016 revenues of $10.9 million.

Testing revenues for the quarter are expected to be $8.4 million to $8.6 million compared with $7.4 million in the same period in 2016, and product revenues are expected to be $3.7 million compared to $3.5 million in Q4 2016.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.